2016 annual financial data
Avalo Therapeutics 2016 Operating margin
Avalo Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -1,394.62%.
Operating income was -16,080,000 USD and net income was -16,471,000 USD.
Operating cash flow was -14,573,138 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,153,000 USD
- Operating income
- -16,080,000 USD
- Net income
- -16,471,000 USD
- Operating cash flow
- -14,573,138 USD